Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 12, 2026
An Aquestive Therapeutics director paid $4.2K out of pocket for Aquestive Therapeutics shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$4,236
Shares × reported transaction price
<$25K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
7 days after results of Nov 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $3.52 on Nov 10, 2026, 19% above its 52-week low and 47% below its high, after a 25% drop over the previous 30 trading days
52-week range $2.95 (Jan 30, 2026) to $6.62 (Dec 8, 2025), 16% of the way up, from 250 adjusted closes. 30 trading days earlier: $4.67 on Sep 29, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any AQST insider since Jun 2022. Richard J Daly's first open-market purchase of AQST in filings since 2018
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 10 · filed 2 days later
Routine share withholding; mechanical by default.
Matthew W Davis (Officer) plans to sell ~$26K of Aquestive Therapeutics
Planned, from payInsider buying
First insider buy since Jun 2022Traded Nov 10 · filed 2 days later
An Aquestive Therapeutics director paid $95K out of pocket for Aquestive Therapeutics shares. Shares held went up 2235% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
